HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Nakaraang pagsara
$22.19
Sakop ng taon
$16.10 - $35.72
Market cap
2.81B USD
Average na Volume
2.84M
P/E ratio
74.73
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 458.58M | 132.98% |
Gastos sa pagpapatakbo | 142.68M | 16.96% |
Net na kita | 215.72M | 475.52% |
Net profit margin | 47.04 | 261.21% |
Kita sa bawat share | 1.67 | 463.04% |
EBITDA | 223.52M | 577.38% |
Aktuwal na % ng binabayarang buwis | 0.28% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 480.23M | 18.96% |
Kabuuang asset | 1.06B | 17.39% |
Kabuuang sagutin | 657.56M | -1.08% |
Kabuuang equity | 401.17M | — |
Natitirang share | 126.53M | — |
Presyo para makapag-book | 7.00 | — |
Return on assets | 59.35% | — |
Return on capital | 74.26% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 215.72M | 475.52% |
Cash mula sa mga operasyon | 108.47M | 218.13% |
Cash mula sa pag-invest | -148.00K | — |
Cash mula sa financing | 793.00K | -68.80% |
Net change in cash | 109.14M | 196.47% |
Malayang cash flow | 17.52M | -76.46% |
Tungkol
Itinatag
2009
Headquarters
Website
Mga Empleyado
708
